Loading…
Kalaris Therapeutics, Inc. is projected to decline to $4.72 by 2027, a -10% move from its current price of $5.24. KLRS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.05 | $5.24 | $5.44 | +0.02% |
| May 30 | $4.98 | $5.24 | $5.52 | +0.03% |
| May 31 | $4.92 | $5.24 | $5.59 | +0.05% |
| Jun 1 | $4.87 | $5.24 | $5.64 | +0.06% |
| Jun 2 | $4.83 | $5.24 | $5.69 | +0.08% |
| Jun 3 | $4.79 | $5.24 | $5.74 | +0.09% |
| Jun 4 | $4.76 | $5.25 | $5.78 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.76 | $5.25 | $5.78 | +0.11% |
| Week 2 | $4.57 | $5.25 | $6.03 | +0.22% |
| Week 3 | $4.44 | $5.26 | $6.22 | +0.32% |
| Week 4 | $4.33 | $5.26 | $6.40 | +0.43% |
| Week 5 | $4.24 | $5.27 | $6.55 | +0.54% |
| Week 6 | $4.15 | $5.27 | $6.70 | +0.65% |
| Week 7 | $4.08 | $5.28 | $6.83 | +0.76% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kalaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases. It focuses on TH103, a clinical-stage anti-VEGF drug for neovascular age-related macular degeneration (nAMD) and for other exudative retinal diseases, currently in Phase 1b/2.
The company was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. It was founded in 2019 and is headquartered in Berkeley Heights, New Jersey.
KLRS trades at $4.92 per share and has a market capitalization of $117.06M, ranking 4154 by size. This places it in the micro-cap tier of the healthcare landscape.
The near-term outlook shows a 2026 forecast with an average price of $4.92, within a range of $4.70 to $6.47, and a NEUTRAL sentiment. Longer-term forecasts suggest a bullish trajectory beginning in 2030, with the average price gradually rising to higher levels and notable upside in later years.
A major floor 31.0% below — a decisive break under it would weaken the trend.
The nearest floor, 10.3% below — buyers have tended to step in here.
The nearest ceiling, 26.0% above — a clean break opens room to run.
A major ceiling 109.5% above — clearing it would confirm fresh momentum.
Key KLRS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KLRS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.06 | Buy | $5.09 | Buy |
| MA 10 | $4.97 | Buy | $5.05 | Buy |
| MA 20 | $5.09 | Buy | $5.21 | Buy |
| MA 50 | $5.79 | Sell | $5.98 | Sell |
| MA 100 | $7.60 | Sell | $6.60 | Sell |
| MA 200 | $6.54 | Sell | $7.03 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.16 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 42.17 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 3.15 | Buy |
| Bollinger %B (20,2) | 0.64 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.94 | Sell |
| Awesome (5,34) | -0.47 | Sell |
| Ultimate (7,14,28) | 57.57 | Neutral |
| Momentum (10) | 0.45 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 5.19 | Buy |
| ADX (14) | 23.75 | Sell |
| ATR (14) | 0.19 | Info |
Near term, the sentiment is NEUTRAL with RSI(14) at 40. The 50-day simple moving average is $5.93 and the 200-day simple moving average is $6.52. Support is at $4.70 and resistance at $6.60. The 30-day price range spans from a low of $3.85 to a high of $6.29.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.70 | $5.24 | $6.97 | 0% | Neutral | |
| $3.62 | $4.72 | $6.59 | -10% | Neutral | |
| $3.70 | $5.02 | $7.34 | -4% | Neutral | |
| $4.66 | $6.52 | $9.89 | +24% | Bullish | |
| $4.60 | $6.63 | $10.36 | +27% | Bullish | |
| $4.71 | $6.97 | $11.18 | +33% | Bullish | |
| $4.77 | $7.24 | $11.90 | +38% | Bullish | |
| $4.15 | $6.44 | $10.81 | +23% | Bullish | |
| $4.39 | $6.97 | $11.93 | +33% | Bullish | |
| $4.89 | $7.95 | $13.84 | +52% | Bullish | |
| $5.45 | $9.80 | $18.40 | +87% | Bullish | |
| $9.14 | $19.78 | $41.36 | +277% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.70 | $5.24 | $6.16 | +0.00% |
| June 2026 | $4.33 | $5.13 | $6.24 | -2.15% |
| July 2026 | $4.44 | $5.31 | $6.58 | +3.64% |
| August 2026 | $4.61 | $5.57 | $7.00 | +4.80% |
| September 2026 | $4.49 | $5.47 | $6.95 | -1.78% |
| October 2026 | $4.35 | $5.33 | $6.84 | -2.58% |
| November 2026 | $4.40 | $5.42 | $7.02 | +1.74% |
| December 2026 | $4.31 | $5.34 | $6.97 | -1.43% |
Click any year to see its month-by-month KLRS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, KLRS is projected to trade between $4.70 and $6.97, averaging $5.24 — a potential gain of 0% from today's $5.24. A consolidation phase looks the most probable path here.
Kalaris Therapeutics, Inc.'s 2027 outlook centres on $4.72, within a $3.62 to $6.59 range. That is -10% versus the projected 2026 average. That marks a -10% change versus current levels. Price action looks broadly range-bound.
By 2028, KLRS could reach as high as $7.34, with a base case around $5.02 and support toward $3.70 — roughly -4% from $5.24. A consolidation phase looks the most probable path here.
Expect KLRS to range from $4.66 to $9.89 through 2029. The $6.52 average target implies a +24% move from current prices. That is up +30% on the projected 2028 average. Momentum favours further upside here.
The KLRS price prediction for 2030 points to an average of $6.63 (low $4.60, high $10.36) — a potential gain of +27% on today's $5.24. Buyers look set to stay in control over this stretch.
In 2031, KLRS is projected to trade between $4.71 and $11.18, averaging $6.97 — a potential gain of +33% from today's $5.24. That is up +5% on the projected 2030 average. Momentum favours further upside here.
Kalaris Therapeutics, Inc.'s 2032 outlook centres on $7.24, within a $4.77 to $11.90 range. That is up +4% on the projected 2031 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, KLRS could reach as high as $10.81, with a base case around $6.44 and support toward $4.15 — roughly +23% from $5.24. Momentum favours further upside here.
Expect KLRS to range from $4.39 to $11.93 through 2034. The $6.97 average target implies a +33% move from current prices. That is up +8% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The KLRS price prediction for 2035 points to an average of $7.95 (low $4.89, high $13.84) — a potential gain of +52% on today's $5.24. Momentum favours further upside here.
In 2040, KLRS is projected to trade between $5.45 and $18.40, averaging $9.80 — a potential gain of +87% from today's $5.24. That is up +23% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Kalaris Therapeutics, Inc.'s 2050 outlook centres on $19.78, within a $9.14 to $41.36 range. That is up +102% on the projected 2040 average. That marks a +277% change versus current levels. Momentum favours further upside here.
Investing $1,000 in KLRS today (≈ 190.839695 KLRS) could be worth
$3,773.97
+$2,773.97 (+277%) by 2050 · US Dollar
Based on the average projected KLRS price of $19.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KLRSwould be worth at today's price.
$1,000 invested in KLRS on May 27, 2025 (≈ 343.642602 KLRS) would be worth
$1,800.69
+$800.69 (+80.1%) today · 1.80× · US Dollar
Based on a KLRS entry price of $2.91 vs. today's $5.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.83 | $1,084.89 | +8.5% |
| 1 month ago | $6.02 | $870.43 | -13.0% |
| 3 months ago | $10.56 | $496.21 | -50.4% |
| 6 months ago | $6.24 | $839.74 | -16.0% |
| 1 year ago | $2.91 | $1,800.69 | +80.1% |
| All time (5.0y) ago | $526.7 | $9.95 | -99.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KLRS forecast.
Our base-case forecast reaches $10.00 around 2050.
Implied market cap at $10.00: $237.92M
The year-by-year forecast shows a mixed start followed by a bullish trajectory into the 2030s. In 2026 the avg is $4.92 with ROI 0 and sentiment NEUTRAL. 2027's avg drops to $4.37 (ROI -11.2), and 2028's avg is $4.62 (ROI -6).
The 2030 forecast improves to an avg of $5.99 with ROI 21.8 and a BULLISH sentiment, followed by 2031 avg $6.35 (ROI 29.1) and 2032 avg $6.53 (ROI 32.8). In 2033 the avg is $5.78 (ROI 17.4), 2034 $6.23 (ROI 26.7), and 2035 $6.97 (ROI 41.7), all with a BULLISH stance.
The outlook strengthens further in 2040 with avg $8.72, max $16.42, ROI 77.2, and a BULLISH sentiment, and culminates in 2050 with avg $17.17, max $36.05, ROI 249, also BULLISH. These are estimates and subject to uncertainty; outcomes depend on clinical results, regulatory decisions, and market conditions.
Tap a question to reveal the answer.
The forecast for 2030 shows min $4.15, avg $5.99, max $9.39 with ROI 21.8 and sentiment BULLISH.
Longer-term forecasts show a bullish tilt from 2030 onward, with increases in average price and ROI (e.g., 2030 avg $5.99, ROI 21.8; 2050 avg $17.17, ROI 249). However, earlier years include mixed results (e.g., 2027 ROI -11.2 and 2028 ROI -6), so the path is uncertain.
Yes. The forecast lists 2031 max $10.21 and 2032 max $10.76, indicating potential to surpass $10 in those years (2030 max is $9.39).
Current price is $4.92. The 30-day range is $3.85 to $6.29.
For 2040, avg $8.72 and max $16.42 with ROI 77.2 and a BULLISH sentiment. For 2050, avg $17.17 and max $36.05 with ROI 249 and a BULLISH sentiment.
Kalaris Therapeutics, Inc. Community Discussion
0Share your Kalaris Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.